Warner Lambert/Sankyo diabetes drug nears market.
出版信息
Nat Biotechnol. 1997 Feb;15(2):113. doi: 10.1038/nbt0297-113.
PMID:9035120
Abstract
摘要
相似文献
1
Warner Lambert/Sankyo diabetes drug nears market.华纳-兰伯特/三共糖尿病药物即将上市。
Nat Biotechnol. 1997 Feb;15(2):113. doi: 10.1038/nbt0297-113.
2
Warner-Lambert voluntarily withdraws Rezulin.华纳-兰伯特公司自愿撤回曲格列酮。
Diabetes Technol Ther. 2000 Summer;2(2):290.
3
Diabetes recall. Though Rezulin's withdrawal is a blow for some patients, there are ways to cope. Here's how.
Time. 2000 Apr 3;155(13):94.
4
Actos (pioglitazone HCL) provides a safe, effective alternative for patients formerly taking Rezulin.艾可拓（盐酸吡格列酮）为曾服用曲格列酮的患者提供了一种安全、有效的替代药物。
Diabetes Technol Ther. 2000 Summer;2(2):290-1.
5
Troglitazone for non-insulin-dependent diabetes mellitus.曲格列酮治疗非胰岛素依赖型糖尿病
Med Lett Drugs Ther. 1997 May 23;39(1001):49-51.
6
A miracle of salamization: positive divided by two equals negative.一个成盐的奇迹：正数除以二等于负数。
Diabet Med. 1997 Nov;14(11):994. doi: 10.1002/(SICI)1096-9136(199711)14:11<994::AID-DIA512>3.0.CO;2-U.
7
Avandia, a leading alternative for Rezulin patients, prescribed to more than 700,000 patients.文迪雅是曲格列酮患者的主要替代药物，已被70多万患者使用。
Diabetes Technol Ther. 2000 Summer;2(2):292.
8
9
Troglitazone: a new class of oral antihyperglycemic for the treatment of type II diabetes.曲格列酮：一种用于治疗II型糖尿病的新型口服降糖药。
Nurse Pract. 1997 Jul;22(7):119-21.
10
New treatment for adult-onset diabetes.成人发病型糖尿病的新疗法。
Nurs Spectr (Wash D C). 1997 Aug 11;7(16):8.
Zotero 插件